Δ9 -Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells

Δ9Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells

(2015) R Rao et al.   BRITISH JOURNAL OF PHARMACOLOGY

Δ9 -Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8

(2015) Jessica Margaret Sido et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Myeloid-Derived Suppressor Cells Accumulate in Kidney Allograft Tolerance and Specifically Suppress Effector T Cell Expansion

(2014) A.-S. Dugast et al.   JOURNAL OF IMMUNOLOGY

mTOR limits the recruitment of CD11b+ Gr1+ Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury

(2014) Yan Zhang et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity

(2014) Wim F.P.M. Van den Hof et al.   TOXICOLOGY

Hepatitis B and liver transplantation: Molecular and clinical features that influence recurrence and outcome

(2014) Tahereh Ghaziani   WORLD JOURNAL OF GASTROENTEROLOGY

Cannabinoid 1 receptors are critical for the innate immune response to TLR4 stimulation

(2013) Marnie Duncan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences

(2013) Janesh Pillay et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Myeloid-derived Suppressor Cells in the Inflammatory Bowel Diseases

(2013) Dmitry V. Ostanin et al.   INFLAMMATORY BOWEL DISEASES

Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation

(2013) E. Gaffal et al.   JOURNAL OF IMMUNOLOGY

Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1

(2013) A. R. Jackson et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction

(2013) Rebecca Hartzell Robinson et al.   Journal of Neuroimmune Pharmacology

The Pharmacologic and Clinical Effects of Medical Cannabis

(2013) Laura M. Borgelt et al.   PHARMACOTHERAPY

Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC)

(2012) Suzanne Ostrand-Rosenberg et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice

(2012) Chi Ma et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Genetic or Pharmaceutical Blockade of Phosphoinositide 3-Kinase P110δ Prevents Chronic Rejection of Heart Allografts

(2012) Huijun Ying et al.   PLoS One

Resveratrol Prevents Endothelial Cells Injury in High-Dose Interleukin-2 Therapy against Melanoma

(2012) Hongbing Guan et al.   PLoS One

Critical Role of Proinflammatory Cytokine IL-6 in Allograft Rejection and Tolerance

(2011) X. Zhao et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

(2011) Eric A. Engels et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1

(2011) Janesh Pillay et al.   JOURNAL OF CLINICAL INVESTIGATION

Chronic Δ-9-tetrahydrocannabinol Administration Increases Lymphocyte CXCR4 Expression in Rhesus Macaques

(2011) Nicole J. LeCapitaine et al.   Journal of Neuroimmune Pharmacology

Targeting Cannabinoid Receptors as a Novel Approach in the Treatment of Graft-versus-Host Disease: Evidence from an Experimental Murine Model

(2011) R. Pandey et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

(2011) C. Meyer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13

(2010) S. L. Highfill et al.   BLOOD

Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties

(2010) Venkatesh L. Hegde et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Interleukin-2 receptor blockade with humanized monoclonal antibody for solid organ transplantation

(2010) Maya Campara et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Cannabinoids and the immune system: An overview

(2010) Radu Tanasescu et al.   IMMUNOBIOLOGY

Steroid minimization in pediatric renal transplantation: Early withdrawal or avoidance?

(2010) Ryszard Grenda et al.   PEDIATRIC TRANSPLANTATION

Do cannabinoids have a therapeutic role in transplantation?

(2010) Mitzi Nagarkatti et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Endotoxin-Induced Myeloid-Derived Suppressor Cells Inhibit Alloimmune Responses via Heme Oxygenase-1

(2009) V. De Wilde et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cannabinoids as novel anti-inflammatory drugs

(2009) Prakash Nagarkatti et al.   Future Medicinal Chemistry

Role of CD44 in the Differentiation of Th1 and Th2 Cells: CD44-Deficiency Enhances the Development of Th2 Effectors in Response to Sheep RBC and Chicken Ovalbumin

(2009) H. Guan et al.   JOURNAL OF IMMUNOLOGY

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

(2008) K. Movahedi et al.   BLOOD

CD28 ligation in the absence of TCR promotes RelA/NF-κB recruitment and trans-activation of the HIV-1 LTR

(2008) Alessandro Annibaldi et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Suppression of T cell costimulator ICOS by  9-tetrahydrocannabinol

(2008) H. Lu et al.   JOURNAL OF LEUKOCYTE BIOLOGY

CB1 and CB2 Cannabinoid Receptors Mediate Different Aspects of Delta-9-Tetrahydrocannabinol (THC)-Induced T Helper Cell Shift Following Immune Activation by Legionella Pneumophila Infection

(2008) Catherine A. Newton et al.   Journal of Neuroimmune Pharmacology

Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells

(2008) V. L. Hegde et al.   MOLECULAR PHARMACOLOGY